CHICAGO--(BUSINESS WIRE)--Timothy P Walbert has been elected as chairman of the iBIO Board of Directors. He succeeds Andrew Hull, Takeda Pharmaceutical, who served as chairman for the past two years and will continue to serve on the Board and Executive Committee as Immediate Past Chairman.
iBIO, founded in 2002, is the industry organization representing biotechnology companies in the biomedical pharmaceutical, medical device and agricultural bioprocessing and bio-industrial sectors in Illinois. iBIO has over 100 members ranging from early-stage startup to Fortune 500 companies.
